Cure51
About:
Cure51 mission is to create a database of cancer survivors to leverage their exceptional biological features.
Website: https://www.cure51.com
Top Investors: Sofinnova Partners, Xavier Niel, Hitachi Ventures, Olivier Pomel, Life Extension Ventures
Description:
Cure51 mission is to create a database of cancer survivors to leverage their exceptional biological features and find new drugs to cure Cancer.
Total Funding Amount:
15M EUR
Headquarters Location:
Paris, Ile-de-France, France
Founded Date:
2021-01-01
Founders:
El Mehdi Ouzgane, Nicolas Wolikow, Simon Istolainen
Number of Employees:
11-50
Last Funding Date:
2024-03-20
IPO Status:
Private
Industries:
© 2025 bioDAO.ai